Sulbactam sodium structure
|
Common Name | Sulbactam sodium | ||
|---|---|---|---|---|
| CAS Number | 69388-84-7 | Molecular Weight | 255.223 | |
| Density | N/A | Boiling Point | 567.7ºC at 760 mmHg | |
| Molecular Formula | C8H10NNaO5S | Melting Point | 121-123 °C(lit.) | |
| MSDS | N/A | Flash Point | 297.1ºC | |
Use of Sulbactam sodiumSulbactam (CP45899) sodium is a competitive, irreversible beta-lactamase inhibitor. Sulbactam sodium shows antimicrobial activity against multidrug-resistant (MDR) acinetobacter calcoaceticus--Acinetobacter baumannii (Acb) complex[1][2]. |
| Name | Sulbactam sodium |
|---|---|
| Synonym | More Synonyms |
| Description | Sulbactam (CP45899) sodium is a competitive, irreversible beta-lactamase inhibitor. Sulbactam sodium shows antimicrobial activity against multidrug-resistant (MDR) acinetobacter calcoaceticus--Acinetobacter baumannii (Acb) complex[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | Ampicillin-Sulbactam has a wide range of antibacterial activity that includes Gram-positive and Gram-negative aerobic and anaerobic bacteria[3]. |
| References |
[1]. Noguchi JK, et al. Sulbactam: a beta-lactamase inhibitor. Clin Pharm. 1988;7(1):37-51. |
| Boiling Point | 567.7ºC at 760 mmHg |
|---|---|
| Melting Point | 121-123 °C(lit.) |
| Molecular Formula | C8H10NNaO5S |
| Molecular Weight | 255.223 |
| Flash Point | 297.1ºC |
| Exact Mass | 255.017731 |
| PSA | 102.96000 |
| InChIKey | NKZMPZCWBSWAOX-IBTYICNHSA-M |
| SMILES | CC1(C)C(C(=O)[O-])N2C(=O)CC2S1(=O)=O.[Na+] |
| Storage condition | -20°C Freezer, Under Inert Atmosphere |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Hazard Codes | Xn: Harmful; |
|---|---|
| Risk Phrases | R42/43 |
| Safety Phrases | S26-S37/39 |
| WGK Germany | 3 |
| HS Code | 2941109900 |
|
~92%
Sulbactam sodium CAS#:69388-84-7 |
| Literature: SANDOZ AG Patent: WO2009/53256 A2, 2009 ; Location in patent: Example 1 ; |
|
~77%
Sulbactam sodium CAS#:69388-84-7 |
| Literature: Leo Pharmaceutical Products Ltd. A/S Patent: US4816580 A1, 1989 ; |
| HS Code | 2941109900 |
|---|
|
Clinical response at Day 3 of therapy and economic outcomes in hospitalized patients with acute bacterial skin and skin structure infection (ABSSSI).
Curr. Med. Res. Opin. 29(7) , 869-77, (2013) The FDA recently issued guidance for the types of infections that should be included in trials to support an indication for antibacterial treatment. The latest FDA guidance recommends assessing respon... |
|
|
Antibiotic regimens for management of intra-amniotic infection.
Cochrane Database Syst. Rev. 12 , CD010976, (2014) Chorioamnionitis is a common infection that affects both mother and infant. Infant complications associated with chorioamnionitis include early neonatal sepsis, pneumonia, and meningitis. Chorioamnion... |
|
|
Anaerobiospirillum succiniciproducens-induced bacteremia in a healthy man.
Am. J. Emerg. Med. 32(7) , 812.e1-3, (2014) Anaerobiospirillum succiniciproducens is rarely associated with bacteremia but results in significant mortality. Almost all reported bacteremia cases have occurred in immunocompromised hosts, such as ... |
|
Name: Discovery of Small Molecules to Inhibit Human Cytomegalovirus Nuclear Egress
Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
Target: HCMV UL50
External Id: HMS1262
|
|
Name: MELAS cybrid survival enhancement under low glucose conditions
Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
Target: N/A
External Id: HMS1419
|
|
Name: Stabilization of p53 in human papillomavirus-positive cells
Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
Target: Cellular tumor antigen p53
External Id: HMS1485
|
| SULBACTAM SODIUM SALT |
| sodium Penicillanate 1,1-Dioxide |
| SulbactaM SodiuM,USP |
| sulbacyam sodium |
| penicillanic acid 1,1-dioxide sodium salt |
| SODIUM SULBACTAM |
| EINECS 273-984-4 |
| Sulbatam Sodium |
| SulbactaM SodiuM API |
| MFCD01750374 |